Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Mirati Therapeutics Net Income 2006-2020 | MRTX

Mirati Therapeutics annual/quarterly net income history and growth rate from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Mirati Therapeutics net income for the quarter ending September 30, 2020 was $-0.087B, a 60.92% increase year-over-year.
  • Mirati Therapeutics net income for the twelve months ending September 30, 2020 was $-0.329B, a 94.63% increase year-over-year.
  • Mirati Therapeutics annual net income for 2019 was $-0.213B, a 116.68% increase from 2018.
  • Mirati Therapeutics annual net income for 2018 was $-0.098B, a 39.74% increase from 2017.
  • Mirati Therapeutics annual net income for 2017 was $-0.07B, a 15.27% decline from 2016.
  
Mirati Therapeutics Annual Net Income
(Millions of US $)
2019 $-213
2018 $-98
2017 $-70
2016 $-83
2015 $-65
2014 $-44
2013 $-53
2012 $-20
2011 $-10
2010 $-14
2009 $-21
2008 $-8
2007 $-21
2006 $-7
2005 $-13
Mirati Therapeutics Quarterly Net Income
(Millions of US $)
2020-09-30 $-87
2020-06-30 $-83
2020-03-31 $-87
2019-12-31 $-72
2019-09-30 $-54
2019-06-30 $-46
2019-03-31 $-41
2018-12-31 $-28
2018-09-30 $-28
2018-06-30 $-28
2018-03-31 $-15
2017-12-31 $-18
2017-09-30 $-16
2017-06-30 $-18
2017-03-31 $-18
2016-12-31 $-20
2016-09-30 $-19
2016-06-30 $-22
2016-03-31 $-22
2015-12-31 $-18
2015-09-30 $-19
2015-06-30 $-15
2015-03-31 $-12
2014-12-31 $-10
2014-09-30 $-9
2014-06-30 $-11
2014-03-31 $-14
2013-12-31 $-11
2013-09-30 $-29
2013-06-30 $-8
2013-03-31 $-4
2012-12-31 $-6
2012-09-30 $-6
2012-06-30 $-5
2012-03-31 $-3
2011-12-31 $-4
2011-09-30 $-3
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-5
2010-06-30 $-3
2010-03-31 $-4
2009-12-31 $-5
2009-09-30 $-5
2009-06-30 $-6
2009-03-31 $-5
2008-12-31 $7
2008-09-30 $-3
2008-06-30 $-7
2008-03-31 $-5
2007-12-31 $-7
2007-09-30 $-5
2007-06-30 $-6
2007-03-31 $-3
2006-12-31 $-2
2006-09-30 $3
2006-06-30 $-4
2006-03-31 $-4
2005-12-31 $-4
2005-09-30 $-3
2005-06-30 $-3
2005-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.387B $0.003B
Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.694B 10.03
Amgen (AMGN) United States $131.896B 13.79
CSL (CSLLY) Australia $100.576B 0.00
Gilead Sciences (GILD) United States $76.628B 10.19
Vertex Pharmaceuticals (VRTX) United States $58.951B 27.41
Moderna (MRNA) United States $56.587B 0.00
Regeneron Pharmaceuticals (REGN) United States $53.901B 19.12
Illumina (ILMN) United States $49.760B 68.44
Biogen (BIIB) United States $37.996B 6.75
Seagen (SGEN) United States $31.921B 84.31
BioNTech SE (BNTX) Germany $27.398B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.863B 10.70
Genmab (GMAB) Denmark $25.117B 29.70
Genmab (GNMSF) Denmark $23.856B 5.49
BeiGene (BGNE) Cayman Islands $20.611B 0.00
Exact Sciences (EXAS) United States $18.714B 0.00
Incyte (INCY) United States $18.017B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.183B 0.00
Bio-Rad Laboratories (BIO.B) United States $16.596B 62.94
Horizon Therapeutics Public (HZNP) Ireland $15.348B 21.94
Alnylam Pharmaceuticals (ALNY) United States $15.042B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.497B 96.22
ARGENX SE-ADR (ARGX) Netherlands $13.533B 0.00
Guardant Health (GH) United States $11.962B 0.00
Sarepta Therapeutics (SRPT) United States $11.835B 0.00
Bio-Techne Corp (TECH) United States $11.518B 73.66
QIAGEN (QGEN) Netherlands $10.873B 24.48
Repligen (RGEN) United States $9.840B 139.55
CRISPR Therapeutics AG (CRSP) Switzerland $9.294B 0.00
Ascendis Pharma (ASND) Denmark $8.987B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.701B 0.00
Galapagos (GLPG) Belgium $8.156B 0.00
Novavax (NVAX) United States $7.988B 0.00
Denali Therapeutics (DNLI) United States $7.497B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.202B 0.00
Acceleron Pharma (XLRN) United States $7.036B 0.00
Adaptive Biotechnologies (ADPT) United States $6.523B 0.00
Amicus Therapeutics (FOLD) United States $6.053B 0.00
Exelixis (EXEL) United States $5.997B 40.27
Blueprint Medicines (BPMC) United States $5.886B 19.49
SWEDISH ORP BIO (BIOVF) Sweden $5.829B 15.93
Halozyme Therapeutics (HALO) United States $5.497B 254.13
Fate Therapeutics (FATE) United States $5.281B 0.00
NeoGenomics (NEO) United States $5.247B 1575.17
Twist Bioscience (TWST) United States $5.196B 0.00
China Biologic Products (CBPO) China $4.677B 30.31
Reata Pharmaceuticals (RETA) United States $4.625B 0.00
Emergent Biosolutions (EBS) United States $4.343B 14.25
Insmed (INSM) United States $4.049B 0.00
Vir Biotechnology (VIR) United States $3.944B 0.00
Legend Biotech (LEGN) United States $3.935B 0.00
Arena Pharmaceuticals (ARNA) United States $3.820B 0.00
MorphoSys AG (MOR) Germany $3.718B 134.57
Eidos Therapeutics (EIDX) United States $3.468B 0.00
Beam Therapeutics (BEAM) United States $3.317B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.237B 0.00
Bluebird Bio (BLUE) United States $3.066B 0.00
Alkermes (ALKS) Ireland $2.995B 29.41
Global Blood Therapeutics (GBT) United States $2.767B 0.00
Zymeworks (ZYME) Canada $2.511B 0.00
Intellia Therapeutics (NTLA) United States $2.427B 0.00
Seres Therapeutics (MCRB) United States $2.293B 0.00
UniQure (QURE) Netherlands $2.255B 0.00
Viela Bio (VIE) United States $2.193B 0.00
PHARMA MAR SA (PHMMF) Spain $2.148B 0.00
I-Mab (IMAB) China $2.118B 0.00
Sorrento Therapeutics (SRNE) United States $2.043B 0.00
Alcobra (ARCT) United States $2.040B 0.00
Inovio Pharmaceuticals (INO) United States $2.028B 0.00
Intra-Cellular Therapies (ITCI) United States $2.015B 0.00
Editas Medicine (EDIT) United States $1.967B 0.00
Amarin (AMRN) Ireland $1.893B 0.00
Mesoblast (MESO) Australia $1.858B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.834B 0.00
Arcus Biosciences (RCUS) United States $1.764B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.688B 0.00
Scholar Rock Holding (SRRK) United States $1.680B 0.00
NGM Biopharmaceuticals (NGM) United States $1.646B 0.00
Mersana Therapeutics (MRSN) United States $1.612B 0.00
Revance Therapeutics (RVNC) United States $1.609B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Precigen (PGEN) United States $1.586B 0.00
Zealand Pharma (ZEAL) Denmark $1.511B 0.00
Sangamo Therapeutics (SGMO) United States $1.412B 0.00
REGENXBIO (RGNX) United States $1.410B 0.00
Myriad Genetics (MYGN) United States $1.394B 0.00
Adverum Biotechnologies (ADVM) United States $1.367B 0.00
Epizyme (EPZM) United States $1.359B 0.00
Coherus BioSciences (CHRS) United States $1.358B 8.98
Ligand Pharmaceuticals (LGND) United States $1.342B 34.77
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Cytokineticsorporated (CYTK) United States $1.274B 0.00
Athenex (ATNX) United States $1.264B 0.00
Northwest Biotherapeutics (NWBO) United States $1.247B 0.00
Genetron Holdings (GTH) China $1.211B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.208B 0.00
Travere Therapeutics (TVTX) United States $1.194B 0.00
Heska (HSKA) United States $1.160B 0.00
Vericel (VCEL) United States $1.130B 0.00
Cellectis S.A (CLLS) France $1.129B 0.00
Codexis (CDXS) United States $1.119B 0.00
Alector (ALEC) United States $1.099B 0.00
Arvinas (ARVN) United States $1.024B 0.00
Pliant Therapeutics (PLRX) United States $1.011B 0.00
Castle Biosciences (CSTL) United States $1.002B 0.00
NantKwest (NK) United States $0.989B 0.00
Morphic Holding (MORF) United States $0.971B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.931B 0.00
Frequency Therapeutics (FREQ) United States $0.921B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.884B 0.00
Pharming Group (PHGUF) Netherlands $0.876B 20.00
Celldex Therapeutics (CLDX) United States $0.866B 0.00
Compugen (CGEN) Israel $0.859B 0.00
Protagonist Therapeutics (PTGX) United States $0.841B 0.00
Cardiff Oncology (CRDF) United States $0.788B 0.00
VBI Vaccines (VBIV) United States $0.784B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
MiMedx (MDXG) United States $0.742B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.738B 37.47
Kadmon Holdings (KDMN) United States $0.732B 0.00
Albireo Pharma (ALBO) United States $0.718B 0.00
Agenus (AGEN) United States $0.690B 0.00
AnaptysBio (ANAB) United States $0.676B 0.00
MannKind (MNKD) United States $0.670B 0.00
Five Prime Therapeutics (FPRX) United States $0.661B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.637B 0.00
Sutro Biopharma (STRO) United States $0.631B 0.00
Precision BioSciences (DTIL) United States $0.609B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.598B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.594B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.592B 0.00
Dynavax Technologies (DVAX) United States $0.578B 0.00
IVERIC Bio (ISEE) United States $0.575B 0.00
Geron (GERN) United States $0.556B 0.00
MeiraGTx Holdings (MGTX) United States $0.542B 0.00
Avid Bioservices (CDMO) United States $0.538B 0.00
Anika Therapeutics (ANIK) United States $0.527B 71.29
Merus (MRUS) Netherlands $0.524B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.517B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.511B 0.00
Forte Biosciences (FBRX) United States $0.500B 0.00
Cel-Sci (CVM) United States $0.478B 0.00
Spero Therapeutics (SPRO) United States $0.470B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.461B 0.00
Puma Biotechnology (PBYI) United States $0.455B 0.00
WAVE Life Sciences (WVE) Singapore $0.448B 0.00
Prothena (PRTA) Ireland $0.442B 0.00
Cue Biopharma (CUE) United States $0.434B 0.00
Clovis Oncology (CLVS) United States $0.430B 0.00
Amryt Pharma (AMYT) United Kingdom $0.429B 0.00
Kala Pharmaceuticals (KALA) United States $0.420B 0.00
UROGEN PHARMA (URGN) United States $0.418B 0.00
Innate Pharma S.A (IPHA) France $0.408B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.404B 0.00
AC Immune SA (ACIU) Switzerland $0.400B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.398B 0.00
Affimed (AFMD) Germany $0.397B 0.00
Starpharma Holdings (SPHRY) Australia $0.396B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 18.33
Trevena (TRVN) United States $0.377B 0.00
Selecta Biosciences (SELB) United States $0.368B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.366B 0.00
Cellular Biomedicine (CBMG) United States $0.363B 0.00
Verastem (VSTM) United States $0.360B 0.00
XOMA (XOMA) United States $0.358B 0.00
Athersys (ATHX) United States $0.352B 0.00
Syros Pharmaceuticals (SYRS) United States $0.350B 0.00
ANI Pharmaceuticals (ANIP) United States $0.350B 8.90
CytomX Therapeutics (CTMX) United States $0.343B 0.00
Arbutus Biopharma (ABUS) United States $0.335B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.305B 0.00
ChromaDex (CDXC) United States $0.303B 0.00
Kamada (KMDA) Israel $0.301B 14.06
IBio (IBIO) United States $0.290B 0.00
PDL BioPharma (PDLI) United States $0.289B 0.00
NextCure (NXTC) United States $0.283B 0.00
CorMedix Inc (CRMD) United States $0.276B 0.00
Pluristem Therapeutics (PSTI) Israel $0.269B 0.00
DBV Technologies S.A (DBVT) France $0.267B 0.00
Fortress Biotech (FBIO) United States $0.262B 0.00
AquaBounty Technologies (AQB) United States $0.256B 0.00
HOOKIPA Pharma (HOOK) United States $0.240B 0.00
Aptinyx (APTX) United States $0.237B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.228B 0.00
TELA Bio (TELA) United States $0.219B 0.00
Nicox SA (NICXF) France $0.207B 0.00
GENFIT S.A (GNFT) France $0.203B 0.00
Aptevo Therapeutics (APVO) United States $0.198B 0.00
Eton Pharmaceuticals (ETON) United States $0.195B 0.00
ADMA Biologics Inc (ADMA) United States $0.188B 0.00
Bellus Health (BLU) Canada $0.186B 0.00
Cerecor (CERC) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.183B 0.00
Idera Pharmaceuticals (IDRA) United States $0.183B 0.00
Theratechnologies (THTX) Canada $0.182B 0.00
Checkpoint Therapeutics (CKPT) United States $0.174B 0.00
Dyadic (DYAI) United States $0.165B 0.00
SESEN BIO, INC (SESN) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
VolitionRX (VNRX) United States $0.160B 0.00
Biofrontera AG (BFRA) Germany $0.158B 0.00
Abeona Therapeutics (ABEO) United States $0.154B 0.00
VTv Therapeutics (VTVT) United States $0.152B 0.00
Kindred Biosciences (KIN) United States $0.151B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Oncobiologics (OTLK) United States $0.148B 0.00
Cogent Biosciences (COGT) United States $0.138B 0.00
Celyad SA (CYAD) Belgium $0.130B 0.00
Applied Genetic Technologies (AGTC) United States $0.129B 0.00
Exicure (XCUR) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Lumos Pharma (LUMO) United States $0.128B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Aytu Bioscience (AYTU) United States $0.112B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
Curis (CRIS) United States $0.111B 0.00
Windtree Therapeutics (WINT) United States $0.109B 0.00
Orgenesis (ORGS) United States $0.106B 220.00
Palatin Technologies (PTN) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Cyclerion Therapeutics (CYCN) United States $0.104B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
Prometic Life Sciences (LMNL) Canada $0.099B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
Novogen (KZIA) Australia $0.095B 0.00
AIT Therapeutics (XAIR) United States $0.094B 0.00
Cidara Therapeutics (CDTX) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Evogene (EVGN) Israel $0.087B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.076B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Soligenix (SNGX) United States $0.069B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 32.63
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Vascular Biogenics (VBLT) Israel $0.062B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.059B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.057B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Seelos Therapeutics (SEEL) United States $0.051B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.044B 0.00
ATyr Pharma (LIFE) United States $0.043B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.040B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
BioCardia (BCDA) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Celsion (CLSN) United States $0.022B 0.00
Spherix (AIKI) United States $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
Advaxis (ADXS) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00